Lv53
848 积分 2025-11-01 加入
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma
1小时前
已完结
Association between temozolomide-related hematologic toxicity and health-related quality of life (HRQoL) in patients with newly diagnosed glioblastoma
1小时前
求助中
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma
18小时前
待确认
Clinical and Genetic Factors Associated With Severe Hematological Toxicity in Glioblastoma Patients During Radiation Plus Temozolomide Treatment
1天前
已完结
Sex-Dependent Analysis of Temozolomide-Induced Myelosuppression and Effects on Survival in a Large Real-life Cohort of Patients With Glioma
1天前
已完结
Optimizing post-operative adjuvant therapy in elderly patients with newly-diagnosed glioblastoma: single-institution audit of clinical outcomes from a tertiary-care comprehensive cancer centre in India
1天前
已关闭
Dose escalation with intraoperative radiotherapy in newly diagnosed glioblastoma (INTRAGO-II): an open-label, multicentre, randomised, controlled, phase 3 trial
1天前
已完结
Are conventional and hypofractionated chemoradiotherapy comparable in glioblastoma patients?
1天前
已完结
The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy
1天前
已完结
Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors
2天前
已完结
皖公网安备34019202002308
